Elevance Health, Inc. - 8-K Filing
Elevance Health reaffirms full-year 2026 earnings guidance of at least $27 per diluted share, excluding net unfavorable items. (Items: 7.01 hereto shall be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended)
Tickers: $ELV